Status:

WITHDRAWN

NOAC Portuguese Real World Study

Lead Sponsor:

Pfizer

Conditions:

Stroke

Systemic Embolism

Eligibility:

All Genders

18+ years

Brief Summary

To determine if there is any difference in the effectiveness and safety outcomes of patients with NVAF newly treated with apixaban, dabigatran, rivaroxaban and vitamin K antagonists

Eligibility Criteria

Inclusion

  • Age ≥18 years on the index date.
  • At least 1 OAC (apixaban, dabigatran, rivaroxaban, VKAs) dispensed during the identification period.

Exclusion

  • Specialty of the physician responsible for the OAC prescription in the index date is one of the following: orthopedics, general surgery, vascular surgery or any other surgical specialty;
  • Duration of OAC therapy during follow-up inferior to the cut-off defined during the feasibility assessment (except if the patient was admitted to in-hospital care during follow-up);
  • The OAC dispensed in the index date was one of the following: dabigatran 75 mg or rivaroxaban 10 mg
  • Hospital claims lacking a diagnosis code indicative of AF during the study period;
  • Hospital claim indicating a diagnosis or procedure code indicative of pregnancy or childbirth during the study period;
  • Hospital claim indicating a diagnosis or procedure code indicative of valvular heart disease, venous thromboembolism, cardiac surgery, pericarditis, hyperthyroidism and thyrotoxicity during the baseline period;
  • Hospital claim indicating a diagnosis or procedure code indicative of hip and knee replacement surgery during the 6 weeks prior to the index date. Patients with past use of OAC will be excluded. Therefore, patients meeting any of the following criteria will be excluded:
  • Had any OAC (apixaban, dabigatran, edoxaban, rivaroxaban, VKAs) dispensed during the 12-month baseline period;
  • Had \>1 OAC dispensed on the index date.

Key Trial Info

Start Date :

June 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2020

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04808934

Start Date

June 1 2020

End Date

December 1 2020

Last Update

April 5 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.